Clinical Trials Sponsored by Valenta Pharm JSC

Total 44 results

Valenta Pharm JSC

Not yet recruiting

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Heartburn | Acid-dependent Diseases of the Gastrointestinal Tract | Symptomatic Treatment of Gastric and Duodenal Ulcers

Russian Federation
Valenta Pharm JSC

Not yet recruiting

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

Viral Infection COVID-19

Russian Federation
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers

Infections

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy Volunteers

COVID-19 | Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19

COVID-19

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of Doxylamine + Pyridoxine, Film-coated, Enteric-soluble Tablets, and Diclectin, Delayed Release Tablets, in Healthy Volunteers

Nausea | Pregnancy Related

Russian Federation
Valenta Pharm JSC

Completed

A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders

Anxiety | Adjustment Disorders | Neurasthenia

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg

Cholecystitis

Russian Federation
Valenta Pharm JSC

Recruiting

Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin

Nausea

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

Influenza | Respiratory Viral Infection

Russian Federation
Valenta Pharm JSC

Completed

A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Influenza | Viral Respiratory Infection | Acute Viral Upper Respiratory Infections

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Study of the Effect of Food Intake on the Bioavailability of XC8 10 mg Film-coated Tablets

Healthy

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Valenta Pharm JSC

Completed

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection | Flu | Viral Infection

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Vespireit, Sustained-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Valenta Pharm JSC

Recruiting

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Cholecystitis

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma

Pyoderma

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Influenza, Human | Common Cold | Acute Respiratory Infection

Russian Federation
Valenta Pharm JSC

Completed

Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets

Healthy

Russian Federation
Valenta Pharm JSC
Atlant Clinical Ltd.

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Influenza, Human | Common Cold | Acute Respiratory Infection | Viral Infection

Russian Federation
Valenta Pharm JSC
Atlant Clinical Ltd.

Completed

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. (ACCORD)

Influenza | Common Cold

Russian Federation
SC Fiterman Pharma SRL

Unknown

Inuline Supplement in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome

Romania
Acasti Pharma Inc.
JSS Medical Research Inc.

Completed

Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia

Hypertriglyceridemia

Canada
H.T. Ensing, PharmD, MSc
Flevoziekenhuis; Zorggroep Almere

Completed

The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge. (HomeCoMe)

Adverse Drug Event | Readmission | Patient Compliance

Netherlands
Acasti Pharma Inc.
JSS Medical Research Inc.

Completed

TRIal For Efficacy of Capre on hyperTriglyceridemiA (TRIFECTA)

Hypertriglyceridemia

Canada
gicare Pharma Inc.
Algorithme Pharma Inc; JSS Medical Research Inc.

Completed

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Pain | Cancer | Colonic Diseases

United States, Canada
R-Pharm International, LLC
R-Pharm; Unimed Laboratories CJSC; Data Management 365; Exacte Labs LLC

Active, not recruiting

Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis

Idiopathic Recurrent Pericarditis

Russian Federation
R-Pharm International, LLC
Unimed Laboratories CJSC; Data Management 365; Center of Pharmaceutical Analytics...

Completed

Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis

Pericarditis

Russian Federation
Pedro Barata, MD, MSc
ESSA Pharma Inc.

Not yet recruiting

Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

United States
Instituto Valenciano de Infertilidad, IVI VALENCIA
Roche Pharma AG

Completed

Follicular Steroid Genesis in Controlled Ovarian Stimulation (ESTEFOL)

Infertility | Controlled Ovarian Hyperstimulation

Spain
Ever Neuro Pharma GmbH
JSW-Research Forschungslabor GmbH, Parkring 12, 8074 Grambach

Completed

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke (CERE-LYSE-1)

Stroke

Austria, Croatia, Czech Republic, Slovakia, Slovenia
R-Pharm International, LLC
Atlant Clinical LLC; Center for Pharmaceutical Analytics LLC; Unimed Laboratories... and other collaborators

Recruiting

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

Familial Mediterranean Fever | FMF

Armenia, Georgia, Russian Federation
R-Pharm International, LLC
R-Pharm; Atlant Clinical LLC; Unimed Laboratories CJSC; Data Management 365; Center...

Recruiting

Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine

Familial Mediterranean Fever | FMF

Armenia, Georgia, Russian Federation
Clementine CM Stuijt PharmD, MSc
Insurance company Achmea Zorg

Unknown

the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes (PITH)

Medication Administered in Error | Adverse Drug Reaction

Netherlands
Glycovax Pharma Inc.
Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.

Active, not recruiting

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

SARS-CoV-2

Australia
R-Pharm
Federal Budget Institution of Science "Central Research Institute of Epidemiology... and other collaborators

Active, not recruiting

Study of Efficacy of Different Treatment Regimens of Olokizumab (RESET)

COVID-19

Russian Federation
Aphaia Pharma US LLC
NovaClin Medical Research Center S.R.L; ACC GmbH Analytical Clinical Concepts; SC Bioclinica... and other collaborators

Completed

Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

Obese

Romania

Clinical Trials Sponsored by Valenta Pharm JSC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations